*ST實達(600734.SH):北京昂展被動減持達1%股份
格隆匯7月9日丨*ST實達(600734.SH)公佈,公司於今日收到公司持股5%以上股東北京昂展科技發展有限公司(“北京昂展”)發來的函吿,北京昂展質押給東吳證券股份有限公司的4150萬股公司股票因其未按相關協議約定履行到期購回義務而構成違約(其中已於2021年7月1日、7月2日被依約賣出合計412.1918萬股),2021年7月5日至7月8日又被再次依約賣出合計210.1805萬股,造成北京昂展所持公司部分股份被動減持。
截至公吿披露日,北京昂展被動減持合計622.3723萬股,約佔公司股本總額的1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.